The Biosimilars Council agrees with the FDA's position that data from a switching study or studies may no longer be necessary to support licensure of interchangeable biosimilar medicines.
The Guidance would support biologic drug competition, increase patient access to biosimilars and lower healthcare costs for patients, the FTC’s comment says.
The new service will empower patients to request delivery for select prescriptions through the Kroger app as soon as their medications are ready for pick up.
